All research
Semaglutide 2026-08-12 PubMed

Amylin-based obesity therapy: a meta-analysis of Cagrilintide and CagriSema versus placebo.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


cagrilintide semaglutide cagrisema obesity weight-loss meta-analysis
Source: pubmed:42583410 · Ingested Aug 12, 2026